PH
Parkman Healthcare Partners LLC disclosed a 5.2% stake in ALGS
Parkman Healthcare Partners LLC reported owning 5.2% of Aligos Therapeutics, Inc. (ALGS) (325,537 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G